Get startedLog in
    Picture of Sihuan Pharmaceutical Holdings logo

    460 — Sihuan Pharmaceutical Holdings Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Sihuan Pharmaceutical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    R2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue3,0382,1811,8611,9012,618
    Cost of Revenue
    Gross Profit2,4301,4881,2961,2421,802
    Selling / General / Administrative Expenses
    Research And Development
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses2,2664,0121,6992,0392,011
    Operating Profit772-1,831162-138607
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes496-2,123-161-428417
    Provision for Income Taxes
    Net Income After Taxes243-2,320-258-472185
    Minority Interest
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income417-1,915-54-217180
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income417-1,915-54-217180
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.048-0.101-0.008-0.0260.017
    Dividends per Share
    Special Dividends per Share